SCHEMBL132948

SCHEMBL132948

CC(C=O)OC1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7367636 1.00
SCHEMBL8314214 1.00
SCHEMBL132947 1.00
SCHEMBL132949 1.00
SCHEMBL4854483 0.82 SLC6A3 (0.30)
SCHEMBL11378266 0.81
SCHEMBL9200841 0.79 MEN1 (0.31)
SCHEMBL271911 0.78 MEN1 (0.30)
SCHEMBL6906276 0.77 MEN1 (0.30)
SCHEMBL9457252 0.77 MEN1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117279898-A Antibacterial compounds 布莱克史密斯医药公司 2023-12-22 CN disclosed
CN-117279897-A Antibacterial compounds 布莱克史密斯医药公司 2023-12-22 CN disclosed
EP-4291550-A1 ANTIBACTERIAL COMPOUNDS Blacksmith Medicines, Inc. (US) 2023-12-20 EP disclosed
WO-2022173758-A1 ANTIBACTERIAL COMPOUNDS FORGE THERAPEUTICS, INC. (US) 2022-08-18 WO disclosed
US-20220002279-A1 NOVEL IMIDAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-01-06 US disclosed
EP-3884940-A1 NOVEL IMIDAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2021-09-29 EP disclosed
EP-3438103-A1 GRISEOFULVIN COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-02-06 EP disclosed
EP-2094673-B1 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY INC (US) 2015-04-08 EP disclosed
US-8461191-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
EP-1768966-B1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY INC (US) 2012-03-07 EP disclosed
EP-1768966-A1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS Infinity Pharmaceuticals, Inc. (US) 2007-04-04 EP disclosed
US-20060025460-A1 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2006-02-02 US disclosed
WO-2006009869-A1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY PHARMACEUTICALS, INC. (US) 2006-01-26 WO disclosed
US-20060020004-A1 Isoxazolidine compounds for treatment of bacterial infections INFINITY PHARMACEUTICALS, INC. (US) 2006-01-26 US disclosed
WO-1999045008-A1 3-[4-(4-CYANOPHENYL)THIAZOL-2-Y)]-1-(1H-1,2,4-TRIAZOL-1-YL)-BUTAN-2-OL DERIVATIVES HAVING ANTIFUNGAL ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 1999-09-10 WO disclosed
EP-0726901-A4 BENZO-FUSED MACROCYCLES PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO INC (US) 1997-01-22 EP disclosed
EP-0726901-A1 BENZO-FUSED MACROCYCLES PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO. INC. (US) 1996-08-21 EP disclosed
US-5438136-A Benzo-fused macrocycles promote release of growth hormone MERCK & CO., INC. (US) 1995-08-01 US disclosed
WO-1995012598-A1 BENZO-FUSED MACROCYCLES PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1995-05-11 WO disclosed
CN-1036759-A Triazole derivative, its preparation method and its purposes as mycocide SANKYO CO (JP) 1989-11-01 CN disclosed